Close Menu

NEW YORK (GenomeWeb) – Maravai LifeSciences announced today that it has acquired Glen Research, a Virginia-based provider of DNA and RNA synthesis reagents.

Specific terms of the deal were not disclosed.

"The acquisition supports our commitment to the genomics market, which we first entered with the acquisition of TriLink BioTechnologies," Maravai President Eric Tardif said in a statement. Maravai acquired TriLink in 2016.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.